Getting Innovations to Patients During Shutdowns Act

Hozzl · 2026-07-12T13:49:30Z

Explore the details of House Bill 9635 Getting Innovations to Patients During Shutdowns Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

7/12/2026, 1:49 PM

Summary of Bill HR 9635

H.R. 9635 of the 119th Congress, introduced on July 9, 2026, aims to amend the Federal Food, Drug, and Cosmetic Act to create specific regulations ensuring the ongoing evaluation of human drug and device submissions in the event of a funding gap.

Read the Full Bill

Formatted XML

Current Status of Bill HR 9635

Bill HR 9635 is currently in the status of Bill Introduced since July 9, 2026. Bill HR 9635 was introduced during Congress 119 and was introduced to the House on July 9, 2026. Bill HR 9635's most recent activity was Referred to the House Committee on Energy and Commerce. as of July 9, 2026

Bipartisan Support of Bill HR 9635

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 9635

Primary Policy Focus

Alternate Title(s) of Bill HR 9635

To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.

Comments

Sterling Finley

1,080

1 month ago

This bill is great for patients during shutdowns. It will help get innovations to those who need it most. The long term effects will be beneficial for all.

Huxley Bowers

1,101

1 month ago

I don't get why this bill is happening. It seems like it's gonna make things worse for us. I hope it doesn't mess things up too much. #confused #bigpicture